Genetic Screening for Synthetic Lethal Partners of Polynucleotide Kinase/Phosphatase: Potential for Targeting SHP-1–Depleted Cancers

This paper elucidates a synthetic lethal combination of target inactivation events that can increase levels of DNA damage that escape repair, suggesting an effective killing paradigm to exploit therapeutically.